PT  - JOURNAL ARTICLE
AU  - Kirkegaard, Julius B.
AU  - Sneppen, Kim
TI  - Variability of Individual Infectiousness Derived from Aggregate Statistics of COVID-19
AID  - 10.1101/2021.01.15.21249870
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.15.21249870
4099  - http://medrxiv.org/content/early/2021/01/15/2021.01.15.21249870.short
4100  - http://medrxiv.org/content/early/2021/01/15/2021.01.15.21249870.full
AB  - The quantification of spreading heterogeneity in the COVID-19 epidemic is crucial as it affects the choice of efficient mitigating strategies irrespective of whether its origin is biological or social. We present a method to deduce temporal and individual variations in the basic reproduction number R directly from epidemic trajectories at a community level. Using epidemic data from the 98 districts in Denmark we estimate an overdispersion factor k for COVID-19 to be about 0.11 (95% confidence interval 0.08 – 0.18), implying that 10 % of the infected cause between 70 % to 87 % of all infections.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has received funding from the Novo Nordisk Foundation, under its Data Science Initiative, Grant Agreement NNF20OC0062047, and from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme, Grant Agreement No. 740704.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Copenhagen.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is publicly available.